Related Experiment Videos
The intermediate syndrome in organophosphate poisoning: an overview of experimental and clinical observations
1University Hospital, Neurology Department, Ghent, Belgium.
Abstract:
The intermediate syndrome of organophosphate poisoning arises in the time interval between the acute cholinergic crisis of fasciculations and muscle weakness and the delayed neuropathy attributed to inhibition of the neuropathy target esterase. The conclusions derived from salient experimental and clinical studies are that intermediate syndrome relates to the severity of poisoning not the specific organophosphate and to prolonged inhibition of acetylcholinesterase activity of the erythrocytes, brain and muscle endplate with pre and post synaptic impairment of neuromuscular transmission. It is not related to delayed neuropathy.
Insights
Organophosphate poisoning intermediate syndrome is linked to poisoning severity, not the specific chemical. It involves prolonged acetylcholinesterase inhibition, affecting neuromuscular transmission, and is distinct from delayed neuropathy.
Area of Science:
- Toxicology
- Neuroscience
- Clinical Medicine
Background:
- Organophosphate (OP) poisoning presents with varied clinical syndromes.
- The intermediate syndrome of organophosphate poisoning (ISP) occurs between acute cholinergic crisis and delayed neuropathy.
- Understanding ISP's pathophysiology is crucial for effective treatment.
Purpose of the Study:
- To elucidate the key features and underlying mechanisms of the intermediate syndrome of organophosphate poisoning.
- To differentiate ISP from acute cholinergic crisis and organophosphate-induced delayed neuropathy (OPIDN).
Main Methods:
- Review of salient experimental and clinical studies on organophosphate poisoning.
- Analysis of factors influencing syndrome development, including OP type and severity.
- Examination of biochemical markers, such as acetylcholinesterase (AChE) activity, and electrophysiological findings.
Main Results:
- Intermediate syndrome of organophosphate poisoning is primarily associated with the severity of poisoning, not the specific organophosphate agent.
- Prolonged inhibition of acetylcholinesterase (AChE) activity in erythrocytes, brain, and muscle endplates is a hallmark of ISP.
- Pre- and post-synaptic impairment of neuromuscular transmission is observed in ISP.
Conclusions:
- Intermediate syndrome of organophosphate poisoning is a distinct clinical entity.
- ISP is characterized by prolonged AChE inhibition and neuromuscular transmission deficits.
- Intermediate syndrome of organophosphate poisoning is not related to organophosphate-induced delayed neuropathy.